ADC Therapeutics SA - Common Shares, par value CHF 0.08 per share (ADCT)

Q: What does CUSIP H0036K147 represent in this 13F holders report?

CUSIP H0036K147 is the security identifier for ADCT - ADC Therapeutics SA - Common Shares, par value CHF 0.08 per share used to aggregate holder disclosures.

Q: How many institutions held ADCT - ADC Therapeutics SA - Common Shares, par value CHF 0.08 per share in Q3 2020?

51 institutional investors reported ADCT - ADC Therapeutics SA - Common Shares, par value CHF 0.08 per share for Q3 2020. Use the holders table for investor-level position and value details.

CUSIP: H0036K147

Q3 2020 13F Holders as of 30 Sep 2020

Type / Class: Equity / Common Shares, par value CHF 0.08 per share
Shares outstanding: 128,210,515
Total 13F shares: 28,226,306
Share change: +6,668,683
Total reported value: $921,776,783
Price per share: $32.99
Number of holders: 51
Value change: +$216,837,760
Number of buys: 37
Number of sells: 12

Quarterly Holders Quick Answers

What is CUSIP H0036K147?
CUSIP H0036K147 identifies ADCT - ADC Therapeutics SA - Common Shares, par value CHF 0.08 per share in SEC institutional holdings data.

Need full ownership history?
Open the full security ownership history page.

Next holder-history checks

These links keep the next click tied to holder verification, nearby quarters, or outside-13F ownership context.

Back to full security ownership history for the broader multi-quarter picture.
Latest 13F filings for newly reported positions across managers.
Latest Schedule 13D/13G reports for ownership changes outside the 13F cadence.
SEC investors directory for manager drilldown.

Explore More Reporting Periods

Jump to adjacent filing periods for faster comparison and easier crawl discovery.

Newer quarter: Q4 2020
Previous quarter: Q2 2020

Recent filing periods for CUSIP H0036K147:

Q1 2026 Q4 2025 Q3 2025 Q2 2025 Q1 2025 Q4 2024 Q3 2024 Q2 2024

Top shareholders of ADCT - ADC Therapeutics SA - Common Shares, par value CHF 0.08 per share (13F + 13D/G + 3/4/5)

Grouped by holder across the latest SEC ownership disclosures. Ownership % is shown only when it is directly reported or safely comparable across share classes.

Methodology: rows are grouped by holder and ranked by the holder's primary source value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.

Holder	Source	Role / Reporting	Ownership %	Shares	Holdings Value	12M Net Δ	As of	Details
Redmile Group, LLC	13F	Company	4.3%	5,525,870	$258,666,000	—	30 Jun 2020	13F
FMR LLC	13F	Company	4.1%	5,244,231	$245,483,000	—	30 Jun 2020	13F
BAKER BROS. ADVISORS LP	13F	Company	1.3%	1,687,500	$78,992,000	—	30 Jun 2020	13F
Magnetar Financial LLC	13F	Company	1.2%	1,563,438	$64,414,000	—	30 Jun 2020	13F
Grosvenor Holdings, L.L.C.	13F	Company	1%	1,277,212	$59,786,000	—	30 Jun 2020	13F
JPMORGAN CHASE & CO	13F	Company	0.89%	1,142,773	$53,493,000	—	30 Jun 2020	13F
ALLIANCEBERNSTEIN L.P.	13F	Company	0.72%	927,577	$43,420,000	—	30 Jun 2020	13F
PRICE T ROWE ASSOCIATES INC /MD/	13F	Company	0.46%	592,251	$27,723,000	—	30 Jun 2020	13F
MPM BioImpact LLC	13F	Company	0.42%	539,648	$25,261,000	—	30 Jun 2020	13F
DEERFIELD MANAGEMENT COMPANY, L.P.	13F	Company	0.39%	500,000	$23,405,000	—	30 Jun 2020	13F
HHLR ADVISORS, LTD.	13F	Company	0.39%	500,000	$23,405,000	—	30 Jun 2020	13F
MATTHEWS INTERNATIONAL CAPITAL MANAGEMENT LLC	13F	Company	0.19%	239,500	$11,211,000	—	30 Jun 2020	13F
PEAK6 Investments LLC	13F	Company	0.18%	233,112	$10,912,000	—	30 Jun 2020	13F
WINTON GROUP Ltd	13F	Company	0.18%	229,000	$10,719,000	—	30 Jun 2020	13F
SUVRETTA CAPITAL MANAGEMENT, LLC	13F	Company	0.14%	175,090	$8,196,000	—	30 Jun 2020	13F
BlackRock Finance, Inc.	13F	Company	0.13%	164,500	$7,700,000	—	30 Jun 2020	13F
PRINCIPAL FINANCIAL GROUP INC	13F	Company	0.12%	153,087	$7,166,000	—	30 Jun 2020	13F
EVENTIDE ASSET MANAGEMENT, LLC	13F	Company	0.12%	150,000	$7,021,000	—	30 Jun 2020	13F
Artal Group S.A.	13F	Company	0.11%	136,000	$6,366,000	—	30 Jun 2020	13F
Burrage Capital Management LLC	13F	Company	0.11%	134,912	$6,315,000	—	30 Jun 2020	13F
UBS AM, a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC	13F	Company	0.06%	78,618	$3,680,109	—	30 Jun 2020	13F
AMERIPRISE FINANCIAL INC	13F	Company	0.05%	64,710	$3,029,000	—	30 Jun 2020	13F
CAAS CAPITAL MANAGEMENT LP	13F	Company	0.03%	35,000	$1,638,000	—	30 Jun 2020	13F
FRED ALGER MANAGEMENT, LLC	13F	Company	0.03%	35,000	$1,638,000	—	30 Jun 2020	13F
Marshall Wace North America L.P.	13F	Company	0.02%	30,990	$1,451,000	—	30 Jun 2020	13F
Pinz Capital Management, LP	13F	Company	0.02%	30,000	$1,405,000	—	30 Jun 2020	13F
CITADEL ADVISORS LLC	13F	Company	0.02%	29,738	$1,392,000	—	30 Jun 2020	13F
VICTORY CAPITAL MANAGEMENT INC	13F	Company	0.02%	26,539	$1,242,000	—	30 Jun 2020	13F
SUSQUEHANNA FUNDAMENTAL INVESTMENTS, LLC	13F	Company	0.02%	25,878	$1,211,000	—	30 Jun 2020	13F
ExodusPoint Capital Management, LP	13F	Company	0.01%	17,425	$816,000	—	30 Jun 2020	13F
MILLENNIUM MANAGEMENT LLC	13F	Company	0.01%	14,887	$697,000	—	30 Jun 2020	13F
Laurion Capital Management LP	13F	Company	0.01%	13,988	$655,000	—	30 Jun 2020	13F
MORGAN STANLEY	13F	Company	0.01%	12,585	$589,000	—	30 Jun 2020	13F
NORGES BANK	13F	Company	0.01%	10,000	$468,000	—	30 Jun 2020	13F
CNA FINANCIAL CORP	13F	Company	0%	4,865	$228,000	—	30 Jun 2020	13F
Endurant Capital Management LP	13F	Company	0%	4,410	$206,000	—	30 Jun 2020	13F
BANK OF AMERICA CORP /DE/	13F	Company	0%	3,510	$164,000	—	30 Jun 2020	13F
Legal & General Group Plc	13F	Company	0%	2,500	$117,000	—	30 Jun 2020	13F
Sterling Investment Advisors, Ltd.	13F	Company	0%	1,000	$46,000	—	30 Jun 2020	13F
OSAIC HOLDINGS, INC.	13F	Company	0%	179	$8,000	—	30 Jun 2020	13F
NumerixS Investment Technologies Inc	13F	Company	0%	100	$5,000	—	30 Jun 2020	13F

Institutional Holders of ADC Therapeutics SA - Common Shares, par value CHF 0.08 per share (ADCT) as of Q3 2020

As of 30 Sep 2020, ADC Therapeutics SA - Common Shares, par value CHF 0.08 per share (ADCT) was held by 51 institutional shareholders that filed Form 13F with the SEC. Together, they reported ownership of 28,226,306 shares. The largest 10 holders included FMR LLC, Redmile Group, LLC, JPMORGAN CHASE & CO, BAKER BROS. ADVISORS LP, Magnetar Financial LLC, Grosvenor Holdings, L.L.C., ALLIANCEBERNSTEIN L.P., PRICE T ROWE ASSOCIATES INC /MD/, EVENTIDE ASSET MANAGEMENT, LLC, and MPM ONCOLOGY IMPACT MANAGEMENT LP. This page lists 51 institutional shareholders reporting positions in this security for the Q3 2020 filing period.

Investor	Option	Weight %	Change %	Value $	* Price	Shares	Share Change	Activity	Report Period

Compare Q3 2020 vs Q2 2020 Across Filers

Q2 2020 holders

Q3 2020 holders

Holder diff

Investor	Q2 2020 Shares	Q3 2020 Shares	Share Diff	Share Chg %	Q2 2020 Value $	Q3 2020 Value $	Value Diff $	Value Chg %

Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).

Quarterly Holders Trend

Quarterly Value Trend

Quarterly Shares Trend

* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.